戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 572901作成日:2026年10月26日

3-Methyl-1,2-cyclopentanedione → 5-(6-{3-[(1H-benzimidazol-2-yl)(1-methylpiperidin-4-yloxy)methyl]-4-fluorophenyl}hex-5-ynylimino)-2-methylcyclopent-1-enol

https://huagongshe.com/reaction/572901

反応式

関与物質

役割名称HCID仕込み量
反応物3-Methyl-1,2-cyclopentanedioneHCID 61209—
反応物OxalateHCID 71081—
反応物6-{3-[(1H-benzimidazol-2-yl)(1-methylpiperidin-4-yloxy)methyl]-4-fluorophenyl}hex-5-ynylamineHCID 66836161—
溶媒EthanolHCID 702—
溶媒WaterHCID 962—
溶媒Sodium HydroxideHCID 14798—
生成物5-(6-{3-[(1H-benzimidazol-2-yl)(1-methylpiperidin-4-yloxy)methyl]-4-fluorophenyl}hex-5-ynylimino)-2-methylcyclopent-1-enolHCID 66835873—

反応手順

A mixture of 6-{3-[(1H-benzimidazol-2-yl)(1-methylpiperidin-4-yloxy)methyl]-4-fluorophenyl}hex-5-ynylamine, oxalate (example 557, 50 mg), 3-methyl-1,2-cyclopentanedione (11.8 mg) in ethanol (2 mL) is refluxed for 2 h. The mixture is then cooled, diluted with water and 1N sodium hydroxide and extracted with ethyl acetate. Pooled extracts are dried over magnesium sulfate and concentrated under reduced pressure. The residue is purified by chromatography over silica gel (gradient dichloromethane/methanol/ammonia from 100/0/0.5 to 95/5/0.5) to afford 5-(6-{3-[(1H-benzimidazol-2-yl)(1-methylpiperidin-4-yloxy)methyl]-4-fluorophenyl}hex-5-ynylimino)-2-methylcyclopent-1-enol. TLC (Eluent: CH2Cl2/MeOH/NH4OH 95/5/0.5) Rf=0.30.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US09029357B2
出典データセットuspto-grants-2015_05
ORD IDord-34c2fae662ec423da2c304810998ff4d
出典メモuspto-grants-2015_05